Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cpi-0610
1. Cpi-0610
2. 1380087-89-7
3. Cpi 0610
4. (s)-2-(6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
5. Chembl4303404
6. Cpi-232
7. U4017guq06
8. Pelabresib
9. Cpi-267232
10. 2-[(4s)-6-(4-chlorophenyl)-1-methyl-4h-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide
11. Cpi0610
12. 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-isoxazolo(5,4-d)(2)benzazepin-4-yl)acetamide
13. 4h-isoxazolo(5,4-d)(2)benzazepine-4-acetamide, 6-(4-chlorophenyl)-1-methyl-, (4s)
14. Pelabresib [inn]
15. Pelabresib Anhydrous
16. Unii-u4017guq06
17. Gtpl9120
18. Schembl15926539
19. Dtxsid201022544
20. Bcp10741
21. Ex-a1612
22. Bdbm50510872
23. Nsc784856
24. S7853
25. Akos030526467
26. Zinc200480149
27. Cs-5592
28. Nsc-784856
29. Compound 10 [pmid: 26815195]
30. Ncgc00483135-01
31. As-73876
32. Bc177446
33. Hy-12863
34. J3.554.939k
35. Q27076907
36. 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
37. 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[e]isoxazolo[5,4-c]azepin-4-yl)acetamide
38. 2-[(7s)-9-(4-chlorophenyl)-3-methyl-5-oxa-4,8-diazatricyclo[8.4.0.0(2),?]tetradeca-1(10),2(6),3,8,11,13-hexaen-7-yl]acetamide
39. 62g
| Molecular Weight | 365.8 g/mol |
|---|---|
| Molecular Formula | C20H16ClN3O2 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 365.0931045 g/mol |
| Monoisotopic Mass | 365.0931045 g/mol |
| Topological Polar Surface Area | 81.5 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 561 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Pelabresib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pelabresib, including repackagers and relabelers. The FDA regulates Pelabresib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pelabresib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pelabresib supplier is an individual or a company that provides Pelabresib active pharmaceutical ingredient (API) or Pelabresib finished formulations upon request. The Pelabresib suppliers may include Pelabresib API manufacturers, exporters, distributors and traders.
Pelabresib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pelabresib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pelabresib GMP manufacturer or Pelabresib GMP API supplier for your needs.
A Pelabresib CoA (Certificate of Analysis) is a formal document that attests to Pelabresib's compliance with Pelabresib specifications and serves as a tool for batch-level quality control.
Pelabresib CoA mostly includes findings from lab analyses of a specific batch. For each Pelabresib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pelabresib may be tested according to a variety of international standards, such as European Pharmacopoeia (Pelabresib EP), Pelabresib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pelabresib USP).
LOOKING FOR A SUPPLIER?
